Influence of pretreatment clinical characteristics on the response rate to mitomycin/vindesine/cisplatin (MVP) in unresectable non-small cell lung cancer
- DOI
- 10.1016/0277-5379(91)90089-v
- Published
- 1991-10
- Container
- European Journal of Cancer and Clinical Oncology
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/0277-5379-91-90089-v,
title = {Influence of pretreatment clinical characteristics on the response rate to mitomycin/vindesine/cisplatin (MVP) in unresectable non-small cell lung cancer},
author = {Marcello Riggi and Pierre Ruffie and Sabine Voisin and Isabelle Monnet and Hubert de Cremoux and Jean Claude Saltiel and Michel Martin and Laurence Vergne and Jocelyne Huet and Esteban Cvitkovic},
year = {1991},
journal = {European Journal of Cancer and Clinical Oncology},
doi = {10.1016/0277-5379(91)90089-v},
url = {https://doi.org/10.1016/0277-5379(91)90089-v}
}RIS
TY - JOUR TI - Influence of pretreatment clinical characteristics on the response rate to mitomycin/vindesine/cisplatin (MVP) in unresectable non-small cell lung cancer AU - Marcello Riggi AU - Pierre Ruffie AU - Sabine Voisin AU - Isabelle Monnet AU - Hubert de Cremoux AU - Jean Claude Saltiel AU - Michel Martin AU - Laurence Vergne AU - Jocelyne Huet AU - Esteban Cvitkovic PY - 1991 JO - European Journal of Cancer and Clinical Oncology DO - 10.1016/0277-5379(91)90089-v UR - https://doi.org/10.1016/0277-5379(91)90089-v ER -
APA
Riggi, M., Ruffie, P., Voisin, S., Monnet, I., Cremoux, H. D., Saltiel, J. C., Martin, M., Vergne, L., Huet, J., & Cvitkovic, E. (1991). Influence of pretreatment clinical characteristics on the response rate to mitomycin/vindesine/cisplatin (MVP) in unresectable non-small cell lung cancer. European Journal of Cancer and Clinical Oncology. https://doi.org/10.1016/0277-5379(91)90089-v
Source records
- crossref · retrieved 2026-09-25T21:09:27.392Z